Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Anthrax Vaccine Clinical Trials [Phase 1]

View source ↗

Summary

Phase 1 clinical trials of an anthrax vaccine sponsored by NICHD have been completed, reporting early safety and immunogenicity data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anthrax vaccine (Anthrax vaccine)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Anthrax | Phase 1 | Status: COMPLETED